Guaifenesin (BioDeep_00000017341)

 

Secondary id: BioDeep_00000398959

human metabolite PANOMIX_OTCML-2023 Chemicals and Drugs


代谢物信息卡片


Guaifenesin for peak identification, European Pharmacopoeia (EP) Reference Standard

化学式: C10H14O4 (198.0892044)
中文名称: 愈创木酚甘油醚, 甘油愈创木酯, 愈创甘油醚, 甲甘苯二醚, 愈甘醚
谱图信息: 最多检出来源 Viridiplantae(plant) 40.5%

分子结构信息

SMILES: COC1=CC=CC=C1OCC(CO)O
InChI: InChI=1S/C10H14O4/c1-13-9-4-2-3-5-10(9)14-7-8(12)6-11/h2-5,8,11-12H,6-7H2,1H3

描述信息

Guaifenesin is a member of methoxybenzenes.
Guaifenesin possesses a storied history, having been originally formally approved by the US FDA in 1952 and continues to be one of very few - if not perhaps the only drug that is readily available and used as an expectorant. Since that time the agent has been a combination component of various prescription and non-prescription over-the-counter cough and cold products and is currently a widely available over-the-counter generic medication. Although it is principally believed that guaifenesin elicits an action to facilitate productive cough to manage chest congestion, it is not known whether the agent can reliably mitigate coughing. Regardless, on March 1, 2007, the FDA received a petition asking the FDA to notify the public that some antitussives, expectorants, decongestants, antihistamines, and cough/cold combinations are not known to be safe and effective in children under the age of 6 years. After the negotiation between FDA and major manufacturers, a voluntary transition of labels for not using guaifenesin in children under the age of 4 years was endorsed by FDA in 2008. Furthermore, there has also been contemporary research to suggest that guaifenesin possesses and is capable of demonstrating anticonvulsant and muscle relaxant effects to some degree possibly by acting as an NMDA receptor antagonist.
Guaifenesin is an Expectorant. The physiologic effect of guaifenesin is by means of Decreased Respiratory Secretion Viscosity, and Increased Respiratory Secretions.
Guaifenesin is a natural product found in Plectranthus with data available.
Guaifenesin is a glyceryl guaiacolate with expectorant effects. Guaifenesin increases respiratory tract mucus secretions, acts as an irritant to gastric vagal receptors and recruits efferent parasympathetic reflexes that cause glandular exocytosis. This agent reduces the viscosity of mucus secretion by reducing adhesiveness and surface tension as well as increasing hydration of mucus. Guaifenesin promotes the efficiency of the mucociliary mechanism important in removing accumulated secretions from the upper and lower airway.
An expectorant that also has some muscle relaxing action. It is used in many cough preparations. [PubChem]
An expectorant that also has some muscle relaxing action. It is used in many cough preparations.
See also: Dextromethorphan Hydrobromide; Guaifenesin (component of); Guaifenesin; Phenylephrine Hydrochloride (component of); Guaifenesin; Pseudoephedrine Hydrochloride (component of) ... View More ...
Guaifenesin (International Noproprietary Name) or guaiphenesin (former British Approved Name) is an expectorant drug usually taken orally to assist the expectoration (bringing up) of phlegm from the airways in acute respiratory tract infections. It is a common ingredient in many over-the-counter cough/cold medications. Guaifenesin is also used in the experimental guaifenesin protocol in the treatment of fibromyalgia. It was first approved by the Food and Drug Administration (FDA) in 1952. Guaifenesin works by drawing water into the bronchi. The water both thins mucus and lubricates the airway, facilitating the removal of mucus by coughing.
Guaifenesin (INN) or guaiphenesin (former BAN) is an expectorant drug usually taken orally to assist the expectoration (bringing up) of phlegm from the airways in acute respiratory tract infections. It is a common ingredient in many over-the-counter cough/cold medications. Guaifenesin is also used in the experimental guaifenesin protocol in the treatment of fibromyalgia. It was first approved by the Food and Drug Administration (FDA) in 1952. Guaifenesin works by drawing water into the bronchi. The water both thins mucus and lubricates the airway, facilitating the removal of mucus by coughing. [HMDB]
R - Respiratory system > R05 - Cough and cold preparations > R05C - Expectorants, excl. combinations with cough suppressants > R05CA - Expectorants
C78273 - Agent Affecting Respiratory System > C29767 - Expectorant
D019141 - Respiratory System Agents > D005100 - Expectorants
Guaifenesin (Guaiacol glyceryl ether), a constituent of guaiac resin from the wood of Guajacum officinale Linné, is an expectorant. Guaifenesin can alleviate cough discomfortby increasing sputum volume and decreasing its viscosity, thereby promoting effective cough[1][2].
Guaifenesin (Guaiacol glyceryl ether), a constituent of guaiac resin from the wood of Guajacum officinale Linné, is an expectorant. Guaifenesin can alleviate cough discomfortby increasing sputum volume and decreasing its viscosity, thereby promoting effective cough[1][2].

同义名列表

437 个代谢物同义名

Guaifenesin for peak identification, European Pharmacopoeia (EP) Reference Standard; Guaifenesin, Pharmaceutical Secondary Standard; Certified Reference Material; InChI=1/C10H14O4/c1-13-9-4-2-3-5-10(9)14-7-8(12)6-11/h2-5,8,11-12H,6-7H2,1H; ( inverted exclamation markA)-3-(o-Methoxyphenoxy)-1,2-propanediol; Little Remedies Little Colds Mucus Relief Expectorant Melt Aways; Guaifenesin, United States Pharmacopeia (USP) Reference Standard; Guaifenesin, European Pharmacopoeia (EP) Reference Standard; Mucinex Fast-Max Chest Congestion Honey and Berry Flavor; Mucinex ChildrensChest Congestion Mini-Melts Bubble Gum; Adult Tussin Mucus and Chest Congestion DM Sugar Free; MAX Tussin Mucus and Chest Congestion Sugar Free; Guaifenesin Directly compressible granules 95\\%; 1,2,3-Propanetriol, ether with 2-methoxyphenol; 1,2-PROPANEDIOL, 3-(2-METHOXYPHENOXY)- (+/-)-; Mucus Relief Extended ReleaseMaximum Strength; 4-06-00-05576 (Beilstein Handbook Reference); Childrens MucinexMini-Melts Chest Congestion; 3-{[2-(methyloxy)phenyl]oxy}propane-1,2-diol; 1,2-Propanediol, 3-(2-methoxyphenoxy)- (+-)-; 1,3-Propanetriol, ether with 2-methoxyphenol; 1,2-PROPANEDIOL, 3-(2-METHOXYPHENOXY)-(+/-)-; The Medicine Shoppe Chest Congestion Relief; good sense tussinmucus and chest congestion; (+/-)-3-(O-METHOXYPHENOXY)-1,2-PROPANEDIOL; Equaline Tussin Mucus and Chest Congestion; (2RS)-3-(2-Methoxyphenoxy)propane-1,2-diol; Akin Expectorant Formula Strawberry Banana; topcare tussinmucus plus chest congestion; CareOne TussinMucus Plus Chest Congestion; (+-)-3-(o-Methoxyphenoxy)-1,2-propanediol; Foster and Thrive Chest Congestion Relief; (2S)-3-(2-methoxyphenoxy)propane-1,2-diol; 1,2-Dihydroxy-3-(2-methoxyphenoxy)propane; EXPECTORANT GUAIFENESIN EXTENDED-RELEASE; DG Health Immediate Release Mucus Relief; Glycerol .alpha.-(2-methoxyphenyl) ether; Always Save Chest Congestion ReliefGUAF; Glycerol .alpha.-(o-methoxyphenyl)ether; Childrens Chest Congestion Relief Grape; Meijer Adult Mucus Pluschest congestion; Preferred Plus Chest Congestion Relief; Tussinadult mucus and chest congestion; Glycerol alpha-(2-methoxyphenyl) ether; Robitussin Mucus Plus Chest Congestion; 1,2-Propanediol, 3-(o-methoxyphenoxy)-; 3-(2-Methoxy-phenoxy)-propane-1,2-diol; Childrens Mucus ReliefChest Congestion; Tussin Mucus and Chest CongestionAdult; Glycerol alpha-(o-methoxyphenyl) ether; 1,2-Propanediol, 3-(2-methoxyphenoxy)-; Premier Value Chest Congestion Relief; 3-(2-Methoxyphenoxy)-1, 2-propanediol; Glycerol alpha-(o-methoxyphenyl)ether; Betr remedies chest congestion relief; Glycerol-alpha-guajakolether [Czech]; 3-(o-Methoxyphenoxy)-propanediol-1,2; Guaiacolic acid, ester with glycerol; 3-(o-Methoxyphenoxy)-1,2-propanediol; 3-(2-methoxyphenoxy)propane-1,2-diol; Glycerol mono(2-methoxyphenyl) ether; 3-(2-Methoxyphenoxy)-1,2-propanediol; Guaiacol glyceryl ether, >=98\\% (GC); Curist Mucus ReliefMaximum Strength; Glycerol mono(2-methoxyphenyl)ether; Glycerol, 1-(2-methoxyphenyl) ether; TussinGuifenesin Expectrorant Syrup; GUAIFENESIN COMPONENT OF MUCINEX DM; Good Neighbor Pharmacy Mucus Relief; Glycerol .alpha.-monoguaiacol ether; Healthmart Chest Congestion Relief; Robitussin Direct Chest Congestion; .alpha.-Glyceryl guaiacolate ether; GUAIFENESIN COMPONENT OF HYCOFENIX; HYCOFENIX COMPONENT OF GUAIFENESIN; Childrens Mucinex Chest Congestion; 3-o-Methoxyphenoxypropane 1:2-diol; GUAIFENESIN COMPONENT OF MUCINEX D; Glycerol a-(2-methoxyphenyl) ether; Guaifenesin [USAN:USP:INN:BAN:JAN]; CVS HEALTH Chest Congestion Relief; Polaramine Expectorant (Salt/Mix); Childrens Chest Congestion Relief; Glycerol a-(o-methoxyphenyl)ether; Glycerol alpha-monoguaiacol ether; Glycerol-alpha-monoguaiacol ether; Childrens MucinexChest Congestion; GUAIFENESIN COMPONENT OF FLOWTUSS; Tussin Mucus and Chest Congestion; tussinmucus plus chest congestion; Refenesen Chest Congestion Relief; Equaline Chest Congestion Relief; Isoclor Expectorant C (Salt/Mix); Scot-tussin Expectorant Sf Cough; Childrens Giltuss EX Expectorant; wal tussinadult chest congestion; alpha-Glyceryl guaiacolate ether; Good Neighbor Pharmacy Tabtussin; rugby mucus and chest congestion; GUAIFENESIN COMPONENT OF OBREDON; Guajacol-glycerinaether [German]; MUCINEX DM COMPONENT GUAIFENESIN; MUCINEX D COMPONENT GUAIFENESIN; Good Neighbor Pharmacy Mucus ER; Berkley and Jensen Mucus Relief; Guajacol-.alpha.-glycerin-ether; component of Colrex Expectorant; TopCare Chest Congestion Relief; Contac Cough Formula (Salt/Mix); Glycerol .alpha.-guaiacyl ether; .alpha.-Glyceryl guaiacol ether; CVS Adult Mucuschest congestion; Meijer Chest Congestion Relief; Shopko Chest Congestion Relief; Glycerol-.alpha.-guajakolether; Glycerol .alpha.-guiacyl ether; FLOWTUSS COMPONENT GUAIFENESIN; Foster and Thrive Mucus Relief; o-Methoxyphenyl glyceryl ether; Adult Tussin Chest Congestion; Mucus ReliefImmediate Release; Tussi-Organidin NR (Salt/Mix); Mucus Relief Extended-Release; alpha-Glyceryl guaiacol ether; Glycerol alpha-guaiacyl ether; Tedral Expectorant (Salt/Mix); Glycerol a-monoguaiacol ether; Maximum Strength Mucus Relief; OBREDON COMPONENT GUAIFENESIN; careone mucus reliefchildrens; Mucus Relief Extended Release; Mucus Relief Chest Congestion; Ru-Tuss DE Tablets (Salt/Mix); Gecolate, Glycodex Injection; Aether glycerinoguaiacolicus; a-Glyceryl guaiacolate ether; tussinexpectorant for adults; Glycerol-alpha-guajakolether; Glycerol alpha-guiacyl ether; tussinadult chest congestion; Mucus ReliefMaximum Strength; Betr chest congestion relief; Guaifenesin Extended-Release; Guajacol-alpha-glycerinether; Quality Choice Mucus Relief; Bronkaid Caplets (Salt/Mix); GUAIFENESIN [USP MONOGRAPH]; GUAIFENESIN (USP MONOGRAPH); Diabetic Tussin Expectorant; ROBITUSSIN CHEST CONGESTION; Glycerin monoguaiacol ether; PV Tussin Tablet (Salt/Mix); Guaifensin Extended-Release; GuaifenesinExtended Release; Guaifenesina [INN-Spanish]; GUAIFENESIN (EP MONOGRAPH); Guaifenesin (Guaiphenesin); Mucus and Chest Congestion; (component of) Deconsal II; GUAIFENESIN [EP MONOGRAPH]; Guaifenesin (JP17/USP/INN); Glycerinmonoguaiacol ether; Glyceryl guaiacolate ether; Pneumotussin HC (Salt/Mix); Guaifenesin(Guaiphenesin); Neothylline-GG (Salt/Mix); GUAIFENESIN [ORANGE BOOK]; Select Brand Mucus Relief; Slo-Phyllin GG (Salt/Mix); Guaifenesinum [INN-Latin]; component of Quibron Plus; Guaifenesine [INN-French]; a-Glyceryl guaiacol ether; Glycerol a-guaiacyl ether; Ether, Guaiacol Glyceryl; 1, 3-(o-methoxyphenoxy)-; Glycerol-a-guajakolether; 1, 3-(2-methoxyphenoxy)-; Theolair Plus (Salt/Mix); Glyceryl Ether, Guaiacol; MMM guaifenesin solution; Robitussin CF (Salt/Mix); Glycerol a-guiacyl ether; GUAIFENESIN [GREEN BOOK]; Adult Tussin Expectorant; Meijer Adult Mucus Plus; Guajacol-glycerinaether; Glyceryl guaiacyl ether; basic care mucus er max; Geri-tussin Expectorant; Guaiacol glyceryl ether; Guaiacyl glyceryl ether; Broncomar ExpectorantSF; Guaiacol glycerin ether; Guaiacol glycerol ether; Glyceryl guaiacol ether; Rugby Cough Guaifenesin; MucinexMaximum Strength; Select Brand Tab Tussin; Guaicol glycerine ether; dg health mucus er max; component of Brondecon; Giltuss EX Expectorant; Refenesen Mucus Relief; Selecthealth Tussin DM; Up and Up Mucus Relief; Childrens Mucus Relief; Guaicol glyceryl ether; Naldecon-EX (Salt/Mix); Lufyllin-GG (Salt/Mix); Glycero-guaiacol ether; Guaiacolglicerinetere; Guaiacolate, Glycerol; component of Hycotuss; DRx ChoiceFruit Punch; Robafen Cough Formula; Pneumomist (Salt/Mix); Kids-EEZEChest Relief; Mucinex DM (Salt/Mix); Guaifenesin Injection; MucusExtended Release; Glycerol guaiacolate; Sunmark Mucus Relief; GUAIFENESIN (USP-RS); Tussar SF (Salt/Mix); component of Quibron; Ritussin Expectorant; Mucinex D (Salt/Mix); GUAIFENESIN [WHO-DD]; 12 Hour Mucus Relief; Glycerin guaiacolate; Brondecon (Salt/Mix); careone mucus relief; GLYCERYL GUAIACOLATE; Congestac (Salt/Mix); caring mill mucus er; GUAIFENESIN [USP-RS]; Brexin EX (Salt/Mix); Palatos Expectorante; Triaminic (Salt/Mix); COMPRESSO GGF 95 SA; Curist Mucus Relief; GUAIFENESIN [VANDF]; Kroger Mucus Relief; Hycotuss (Salt/Mix); Good Sense Mucus ER; GUAIFENESIN (MART.); Tussar-2 (Salt/Mix); Q-Tussin (Salt/Mix); GUAIFENESIN [MART.]; Safrel Mucus Relief; Glyceryl guiacolate; basic care mucus er; Glyceryl guaicolate; TopCare Tab Tussin; Tedral Expectorant; Topco Mucus Relief; welby mucus relief; GUAIFENESIN [USAN]; Colrex expectorant; Methoxypropanediol; Tussin Expectorant; Marcs Mucus Relief; Dg Health Mucus ER; Kwelcof (Salt/Mix); Metossipropandiolo; Dilor G (Salt/Mix); Simpex Guaifenesin; GUAIFENESIN [HSDB]; Dimacol (Salt/Mix); TussinEXPECTORANT; Prestwick3_000776; GUAIFENESIN [INN]; GUAIFENESIN [JAN]; Prestwick2_000776; Prestwick1_000776; Prestwick0_000776; Mucosa Guifenesin; Glyceryl guaiacol; GUAIFENESIN-ODAAT; Leader Cough Tabs; Mucus Relief Max; Entex (Salt/Mix); Glycerylguaiacol; Reeses TABtussin; Spectrum4_000566; Spectrum5_000758; WLN: Q1YQ1OR BO1; Topcare Mucus ER; GUAIFENESIN [MI]; p-Cresyl acetate; Spectrum2_001104; Spectrum3_000444; rac Guaifenesin; CVS Adult Mucus; Methphenoxydiol; ROBITUSSIN (TN); Metfenossidiolo; Guaifenesin,(S); Tox21_110389_1; WalgreenCherry; Sunmark Tussin; glycerin ether; Gadavyt Cough; Guaifenesinum; Rompe PechoEX; BPBio1_000938; DivK1c_000248; Rompe PechoSF; Guaiphenesine; Hustosil (TN); Guaiphenezine; Oprea1_193170; KBio2_006451; Guaifenesine; Guiaphenesin; Guaiphenesin; KBio1_000248; KBio2_001315; Tussin Chest; Scott-Tussin; KBio3_001308; Tox21_110389; Siltussin Sa; Tox21_302094; Scott Tussin; Guaifenesina; Organidin NR; KBio2_003883; Propanosedyl; Geri-Tussin; Lufyllin-GG; ScottTussin; Guaiacurane; Guiafenesin; Gnaifenesin; BroncomarSF; CAS-93-14-1; IDI1_000248; Guaifenesin; Guaianesin; Pneumomist; Muca Clear; DRx Choice; Guaifensin; Guaiacuran; Muskurelax; Ultra Tuss; Guayanesin; wal tussin; Robitussin; Guifenesin; Organ-I Nr; Guaiphesin; Guajacuran; Flartussin; Amonidren; Liqufruta; AI3-24947; Myoscaine; Guailaxin; Amonidrin; Relaxyl-G; Benylin-E; Air Power; Cough Out; Reorganin; Cortussin; Actifed C; Pharbinex; Breonesin; Guaia-rom; Aeronesin; Neurotone; Relaxil G; Glycotuss; TusnelEX; Q-Tussin; Calmipan; Miocaina; Tenntuss; Myorelax; Guaiamar; Bronchol; Miocurin; Hustodil; Guiatuss; Myoscain; Gecolate; Dorassin; Miorelax; Guajamar; Hustosil; Mucostop; Glycodex; Neuroton; Ritussin; Mintosyl; Myocaine; Respenyl; Reduton; R05CA03; Gaiamar; Tenntus; Mucinex; Equicol; Myocain; EXCAUGH; HUMABID; MUCUSOL; Sirotol; Humibid; Aresol; Oreson; Hytuss; Creson; Trecid; Oresol; Guanar; Tussin; Mucosa; Respil; Mucus; Guaap; Gvaja; Resyl; Tolyn; Tulyn; Dilyn; Resil; SL-90; XL-90; Tulyl; Glyc; G 87; Akin; 2/G; 2-G



数据库引用编号

16 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

3 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Yunyuan Huang, Haiyan Xu, Pei Wang, Rurong Gu, Xiaokang Li, Yixiang Xu, Jiqun Wang, Sicong Qiao, Donglei Shi, Zhaobing Gao, Jian Li. Identification of Guaifenesin-Andrographolide as a Novel Combinatorial Drug Therapy for Epilepsy Using Network Virtual Screening and Experimental Validation. ACS chemical neuroscience. 2022 04; 13(7):978-986. doi: 10.1021/acschemneuro.1c00774. [PMID: 35333519]
  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Hasan Işık, Gökçe Öztürk, Fatma Ağın, Dilek Kul. Electroanalytical Analysis of Guaifenesin on Poly(Acridine Orange) Modified Glassy Carbon Electrode and its Determination in Pharmaceuticals and Serum Samples. Combinatorial chemistry & high throughput screening. 2021; 24(3):376-385. doi: 10.2174/1386207323666200709170450. [PMID: 32646355]
  • Tanya Duke-Novakovski, Carolina Palacios Jimenez, Masako Fujiyama, Shannon G Beazley. Plasma histamine concentrations in horses administered sodium penicillin, guaifenesin-xylazine-ketamine and isoflurane with morphine or butorphanol. Veterinary anaesthesia and analgesia. 2021 Jan; 48(1):17-25. doi: 10.1016/j.vaa.2020.10.003. [PMID: 33229232]
  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • Yi Kuang, Bin Li, Jingran Fan, Xue Qiao, Min Ye. Antitussive and expectorant activities of licorice and its major compounds. Bioorganic & medicinal chemistry. 2018 01; 26(1):278-284. doi: 10.1016/j.bmc.2017.11.046. [PMID: 29224994]
  • Samaa Alrushaid, Neal M Davies, Judy E Anderson, Tyson Le, Jaime A Yáñez, Zaid H Maayah, Ayman O S El-Kadi, Ousama Rachid, Casey L Sayre, Raimar Löbenberg, Frank J Burczynski. Pharmaceutical Characterization of MyoNovin, a Novel Skeletal Muscle Regenerator: in silico, in vitro and in vivo Studies. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 2018; 21(1s):29683. doi: 10.18433/j3ms8h. [PMID: 29702047]
  • Shuhua Deng, Wencan Huang, Xiaojia Ni, Ming Zhang, Haoyang Lu, Zhanzhang Wang, Jinqing Hu, Xiuqing Zhu, Chang Qiu, Dewei Shang, Yuefeng Zhang, Linghui Xiong, Yuguan Wen. Pharmacokinetics of guaifenesin, pseudoephedrine and hydrocodone in a combination oral liquid formulation, administered as single and multiple doses in healthy Chinese volunteers, and comparison with data for individual compounds formulated as Antuss®. Xenobiotica; the fate of foreign compounds in biological systems. 2017 Oct; 47(10):870-878. doi: 10.1080/00498254.2016.1241451. [PMID: 27662264]
  • A M Kolbach-Mandel, N S Mandel, S R Cohen, J G Kleinman, F Ahmed, I C Mandel, J A Wesson. Guaifenesin stone matrix proteomics: a protocol for identifying proteins critical to stone formation. Urolithiasis. 2017 Apr; 45(2):139-149. doi: 10.1007/s00240-016-0907-4. [PMID: 27435233]
  • Helmut H Albrecht, Peter V Dicpinigaitis, Eric P Guenin. Role of guaifenesin in the management of chronic bronchitis and upper respiratory tract infections. Multidisciplinary respiratory medicine. 2017; 12(?):31. doi: 10.1186/s40248-017-0113-4. [PMID: 29238574]
  • H K Knych, S D Stanley, D Benson, R M Arthur. Pharmacokinetics of guaifenesin following administration of multiple doses to exercised Thoroughbred horses. Journal of veterinary pharmacology and therapeutics. 2016 Aug; 39(4):416-9. doi: 10.1111/jvp.12287. [PMID: 26763117]
  • Gary A Thompson, Gail Solomon, Helmut H Albrecht, Donald P Reitberg, Eric Guenin. Guaifenesin Pharmacokinetics Following Single-Dose Oral Administration in Children Aged 2 to 17 Years. Journal of clinical pharmacology. 2016 07; 56(7):894-901. doi: 10.1002/jcph.682. [PMID: 26632082]
  • Shannu Palamuru, Nikki Dellas, Stephen L Pearce, Andrew C Warden, John G Oakeshott, Gunjan Pandey. Phylogenetic and kinetic characterization of a suite of dehydrogenases from a newly isolated bacterium, strain SG61-1L, that catalyze the turnover of guaiacylglycerol-β-guaiacyl ether stereoisomers. Applied and environmental microbiology. 2015 Dec; 81(23):8164-76. doi: 10.1128/aem.01573-15. [PMID: 26386069]
  • Hadir M Maher, Shorog M Al-Taweel, Mona M Alshehri, Nourah Z Alzoman. Novel stereoselective high-performance liquid chromatographic method for simultaneous determination of guaifenesin and ketorolac enantiomers in human plasma. Chirality. 2014 Oct; 26(10):629-39. doi: 10.1002/chir.22354. [PMID: 25043279]
  • Evan Small, Benjamin J Sandefur. Acute renal failure after ingestion of guaifenesin and dextromethorphan. The Journal of emergency medicine. 2014 Jul; 47(1):26-9. doi: 10.1016/j.jemermed.2014.01.022. [PMID: 24630853]
  • M J Rumpler, P Colahan, R A Sams. The pharmacokinetics of methocarbamol and guaifenesin after single intravenous and multiple-dose oral administration of methocarbamol in the horse. Journal of veterinary pharmacology and therapeutics. 2014 Feb; 37(1):25-34. doi: 10.1111/jvp.12068. [PMID: 23859819]
  • Osman Duman, Sibel Tunç, Bahar Kancı Bozoğlan. Characterization of the binding of metoprolol tartrate and guaifenesin drugs to human serum albumin and human hemoglobin proteins by fluorescence and circular dichroism spectroscopy. Journal of fluorescence. 2013 Jul; 23(4):659-69. doi: 10.1007/s10895-013-1177-y. [PMID: 23471625]
  • Merisa Okic, Tom Johnson, Joseph A Crifasi, Christopher Long, Erik K Mitchell. Swift onset of central nervous system depression and asystole followingan overdose of Guaifenesin. Journal of analytical toxicology. 2013 Jun; 37(5):318-9. doi: 10.1093/jat/bkt030. [PMID: 23580607]
  • Daniel J Warner, Hongming Chen, Louis-David Cantin, J Gerry Kenna, Simone Stahl, Clare L Walker, Tobias Noeske. Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals. 2012 Dec; 40(12):2332-41. doi: 10.1124/dmd.112.047068. [PMID: 22961681]
  • Mehdi Hatami, Khalil Farhadi. Application of hollow fiber-supported liquid-phase microextraction coupled with HPLC for the determination of guaifenesin enantiomer-protein binding. Biomedical chromatography : BMC. 2012 Jul; 26(7):875-80. doi: 10.1002/bmc.1746. [PMID: 22102436]
  • Ziyan Hu, Qiaogen Zou, Jixin Tian, Lili Sun, Zunjian Zhang. Simultaneous determination of codeine, ephedrine, guaiphenesin and chlorpheniramine in beagle dog plasma using high performance liquid chromatography coupled with tandem mass spectrometric detection: application to a bioequivalence study. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2011 Dec; 879(32):3937-42. doi: 10.1016/j.jchromb.2011.11.001. [PMID: 22119507]
  • Robert J Brosnan, Eugene P Steffey, André Escobar, Mine Palazoglu, Oliver Fiehn. Anesthetic induction with guaifenesin and propofol in adult horses. American journal of veterinary research. 2011 Dec; 72(12):1569-75. doi: 10.2460/ajvr.72.12.1569. [PMID: 22126682]
  • Mehdi Hatami, Khalil Farhadi, Assem Abdollahpour. Using dispersive liquid-liquid microextraction and liquid chromatography for determination of guaifenesin enantiomers in human urine. Journal of separation science. 2011 Nov; 34(21):2933-9. doi: 10.1002/jssc.201100520. [PMID: 21972192]
  • Wendy A Goodwin, Helen L Keates, Kirby Pasloske, Martin Pearson, Ben Sauer, Millaganamada Gedara Ranasinghe. The pharmacokinetics and pharmacodynamics of the injectable anaesthetic alfaxalone in the horse. Veterinary anaesthesia and analgesia. 2011 Sep; 38(5):431-8. doi: 10.1111/j.1467-2995.2011.00634.x. [PMID: 21831048]
  • B P S Thakur, S K Sharma, Arvind Sharma, Adarsh Kumar. Clinical evaluation of detomidine-butorphanol-guaifenesin-ketamine as short term TIVA in Spiti ponies. Pakistan journal of biological sciences : PJBS. 2011 Jun; 14(11):647-52. doi: 10.3923/pjbs.2011.647.652. [PMID: 22235506]
  • Steven Gabardi, Danielle Carter, Spencer Martin, Keri Roberts. Recommendations for the proper use of nonprescription cough suppressants and expectorants in solid-organ transplant recipients. Progress in transplantation (Aliso Viejo, Calif.). 2011 Mar; 21(1):6-13; quiz 14. doi: 10.7182/prtr.21.1.t837123h2350721j. [PMID: 21485938]
  • Yang Yong-hong, Wang Dao-xin. [The relationship between the lung function and the level of TNF-α in serum in COPD department of respiratory]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology. 2010 Sep; 26(9):887-8. doi: NULL. [PMID: 21140973]
  • Jinhua Wen, Hong Zhang, Chunhua Xia, Xiao Hu, Wenwei Xu, Xiaohua Cheng, Jun Gao, Yuqing Xiong. A sensitive liquid chromatography-electrospray ionization-mass spectrometry method for the simultaneous determination of pentoxyverine citrate and guaifenesin in human plasma---application to pharmacokinetic and bioequivalence studies. Biomedical chromatography : BMC. 2010 Apr; 24(4):351-7. doi: 10.1002/bmc.1298. [PMID: 19634120]
  • Christian Langel, Cristian Grossmann, Massimo Morbidelli, Manfred Morari, Marco Mazzotti. Implementation of an automated on-line high-performance liquid chromatography monitoring system for 'cycle to cycle' control of simulated moving beds. Journal of chromatography. A. 2009 Dec; 1216(50):8806-15. doi: 10.1016/j.chroma.2009.02.005. [PMID: 19264313]
  • Jiri Sliva, Tomas Dolezal, David Sykora, Magda Vosmanska, Miloslav Krsiak. Guaifenesin enhances the analgesic potency of ibuprofen, nimesulide and celecoxib in mice. Neuro endocrinology letters. 2009; 30(3):352-6. doi: NULL. [PMID: 19855358]
  • Mohammad Amanullah, Cristian Grossmann, Marco Mazzotti, Manfred Morari, Massimo Morbidelli. Experimental implementation of automatic 'cycle to cycle' control of a chiral simulated moving bed separation. Journal of chromatography. A. 2007 Sep; 1165(1-2):100-8. doi: 10.1016/j.chroma.2007.07.065. [PMID: 17707852]
  • Thomas H Eichhold, David L McCauley-Myers, Deepa A Khambe, Gary A Thompson, Steven H Hoke. Simultaneous determination of dextromethorphan, dextrorphan, and guaifenesin in human plasma using semi-automated liquid/liquid extraction and gradient liquid chromatography tandem mass spectrometry. Journal of pharmaceutical and biomedical analysis. 2007 Jan; 43(2):586-600. doi: 10.1016/j.jpba.2006.07.018. [PMID: 16930908]
  • Darien J Feary, Khursheed R Mama, Ann E Wagner, Sara Thomasy. Influence of general anesthesia on pharmacokinetics of intravenous lidocaine infusion in horses. American journal of veterinary research. 2005 Apr; 66(4):574-80. doi: 10.2460/ajvr.2005.66.574. [PMID: 15900935]
  • Xiaoyan Chen, Jia Huang, Zhang Kong, Dafang Zhong. Sensitive liquid chromatography-tandem mass spectrometry method for the simultaneous determination of paracetamol and guaifenesin in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2005 Mar; 817(2):263-9. doi: 10.1016/j.jchromb.2004.12.011. [PMID: 15686994]
  • Stéphane Besombes, Karim Mazeau. The cellulose/lignin assembly assessed by molecular modeling. Part 1: adsorption of a threo guaiacyl beta-O-4 dimer onto a Ibeta cellulose whisker. Plant physiology and biochemistry : PPB. 2005 Mar; 43(3):299-308. doi: 10.1016/j.plaphy.2005.02.005. [PMID: 15854839]
  • Debbie L Kuhlenbeck, Thomas H Eichold, Steven H Hoke, Timothy R Baker, Robert Mensen, Kenneth R Wehmeyer. On-line solid phase extraction using the Prospekt-2 coupled with a liquid chromatography/tandem mass spectrometer for the determination of dextromethorphan, dextrorphan and guaifenesin in human plasma. European journal of mass spectrometry (Chichester, England). 2005; 11(2):199-208. doi: 10.1255/ejms.737. [PMID: 16046804]
  • Stephen Bennett, Nathan Hoffman, Manoj Monga. Ephedrine- and guaifenesin-induced nephrolithiasis. Journal of alternative and complementary medicine (New York, N.Y.). 2004 Dec; 10(6):967-9. doi: 10.1089/acm.2004.10.967. [PMID: 15673990]
  • Maged H M Sharaf, Dwight D Stiff. Determination of guaifenesin in human serum by capillary gas chromatography and electron capture detection. Journal of pharmaceutical and biomedical analysis. 2004 Jun; 35(4):801-6. doi: 10.1016/j.jpba.2004.01.028. [PMID: 15193724]
  • Nathan Hoffman, Shawn M McGee, John C Hulbert. Resolution of ephedrine stones with dissolution therapy. Urology. 2003 May; 61(5):1035. doi: 10.1016/s0090-4295(02)02593-1. [PMID: 12736038]
  • J H Check. Successful pregnancy despite advanced age and elevated serum follicle stimulating hormone levels--a case report. Clinical and experimental obstetrics & gynecology. 2000; 27(3-4):171-2. doi: NULL. [PMID: 11214941]
  • D G Assimos, P Langenstroer, R F Leinbach, N S Mandel, J M Stern, R P Holmes. Guaifenesin- and ephedrine-induced stones. Journal of endourology. 1999 Nov; 13(9):665-7. doi: 10.1089/end.1999.13.665. [PMID: 10608519]
  • H Wogoman, M Steinberg, A J Jenkins. Acute intoxication with guaifenesin, diphenhydramine, and chlorpheniramine. The American journal of forensic medicine and pathology. 1999 Jun; 20(2):199-202. doi: 10.1097/00000433-199906000-00018. [PMID: 10414664]
  • S Demirbas, L Reyderman, S Stavchansky. Bioavailability of dextromethorphan (as dextrorphan) from sustained release formulations in the presence of guaifenesin in human volunteers. Biopharmaceutics & drug disposition. 1998 Nov; 19(8):541-5. doi: 10.1002/(sici)1099-081x(1998110)19:8<541::aid-bdd138>3.0.co;2-8. [PMID: 9840216]
  • P M Taylor, J J Kirby, D J Shrimpton, C B Johnson. Cardiovascular effects of surgical castration during anaesthesia maintained with halothane or infusion of detomidine, ketamine and guaifenesin in ponies. Equine veterinary journal. 1998 Jul; 30(4):304-9. doi: 10.1111/j.2042-3306.1998.tb04102.x. [PMID: 9705113]
  • N S Matthews, K E Peck, K L Mealey, T S Taylor, A C Ray. Pharmacokinetics and cardiopulmonary effects of guaifenesin in donkeys. Journal of veterinary pharmacology and therapeutics. 1997 Dec; 20(6):442-6. doi: 10.1046/j.1365-2885.1997.00081.x. [PMID: 9430767]
  • P M Taylor, S P Luna, J W Sear, M J Wheeler. Total intravenous anaesthesia in ponies using detomidine, ketamine and guaiphenesin: pharmacokinetics, cardiopulmonary and endocrine effects. Research in veterinary science. 1995 Jul; 59(1):17-23. doi: 10.1016/0034-5288(95)90024-1. [PMID: 8525079]
  • V Pade, J Aluri, L Manning, S Stavchansky. Bioavailability of pseudoephedrine from controlled release formulations in the presence of guaifenesin in human volunteers. Biopharmaceutics & drug disposition. 1995 Jul; 16(5):381-91. doi: 10.1002/bdd.2510160503. [PMID: 8527687]
  • S Stavchansky, S Demirbas, L Reyderman, C K Chai. Simultaneous determination of dextrorphan and guaifenesin in human plasma by liquid chromatography with fluorescence detection. Journal of pharmaceutical and biomedical analysis. 1995 Jun; 13(7):919-25. doi: 10.1016/0731-7085(95)01506-g. [PMID: 8562617]
  • Y Hikasa, K Takase, S Ogasawara. Sevoflurane and oxygen anaesthesia following administration of atropine-xylazine-guaifenesin-thiopental in spontaneously breathing horses. Zentralblatt fur Veterinarmedizin. Reihe A. 1994 Nov; 41(9):700-8. doi: 10.1111/j.1439-0442.1994.tb00138.x. [PMID: 7732748]
  • M H Brock, R J Dansereau, V S Patel. Use of in vitro and in vivo data in the design, development, and quality control of sustained-release decongestant dosage forms. Pharmacotherapy. 1994 Jul; 14(4):430-7. doi: NULL. [PMID: 7524044]
  • Y Hikasa, K Takase, K Kondou, S Ogasawara. Sevoflurane anesthesia following administration of atropine-guaifenesin-thiopental in spontaneous-breathing adult cattle. The Journal of veterinary medical science. 1994 Jun; 56(3):613-6. doi: 10.1292/jvms.56.613. [PMID: 7948408]
  • P van Dijk. Intravenous anaesthesia in horses by guaiphenesin-ketamine-detomidine infusion: some effects. The veterinary quarterly. 1994 May; 16 Suppl 2(?):S122-4. doi: NULL. [PMID: 7801504]
  • J B Aluri, S Stavchansky. Determination of guaifenesin in human plasma by liquid chromatography in the presence of pseudoephedrine. Journal of pharmaceutical and biomedical analysis. 1993 Sep; 11(9):803-8. doi: 10.1016/0731-7085(93)80072-9. [PMID: 8218524]
  • L E Young, D H Bartram, M J Diamond, A S Gregg, R S Jones. Clinical evaluation of an infusion of xylazine, guaifenesin and ketamine for maintenance of anaesthesia in horses. Equine veterinary journal. 1993 Mar; 25(2):115-9. doi: 10.1111/j.2042-3306.1993.tb02919.x. [PMID: 8467769]
  • W W Muir, R A Sams, S Ashcraft. The pharmacology and pharmacokinetics of high-dose methocarbamol in horses. Equine veterinary journal. Supplement. 1992 Feb; ?(11):41-4. doi: 10.1111/j.2042-3306.1992.tb04771.x. [PMID: 9109959]
  • J E McCarty, C M Trim, D Ferguson. Prolongation of anesthesia with xylazine, ketamine, and guaifenesin in horses: 64 cases (1986-1989). Journal of the American Veterinary Medical Association. 1990 Dec; 197(12):1646-50. doi: NULL. [PMID: 2276967]
  • R Wall, W W Muir. Hemolytic potential of guaifenesin in cattle. The Cornell veterinarian. 1990 Apr; 80(2):209-16. doi: NULL. [PMID: 2318045]
  • F Gasthuys, R Vandamme, A De Moor, W De Meurichy. Haemodynamic, metabolic and physical responses to a neuroleptanalgesic-glyceryl guaiacolate combination in the horse. Veterinary research communications. 1989; 13(2):113-26. doi: 10.1007/bf00346721. [PMID: 2505440]
  • S D Semrad, C M Trim, G E Hardee. Hypertension in bulls and steers anesthetized with guaifenesin-thiobarbiturate-halothane combination. American journal of veterinary research. 1986 Jul; 47(7):1577-82. doi: . [PMID: 3740628]
  • A B Straughn, G C Wood, G Raghow, M C Meyer. Bioavailability of dyphylline and dyphylline-guaifenesin tablets in humans. Journal of pharmaceutical sciences. 1985 Mar; 74(3):335-7. doi: 10.1002/jps.2600740324. [PMID: 4009445]
  • H C Ketelaars, J G Peters, R B Anzion, C A Van Ginneken. Isolation, partial identification and quantitative determination of four guaiphenesin glucuronides in plasma and urine of the horse by high-performance liquid chromatography. Journal of chromatography. 1984 Apr; 288(2):423-9. doi: 10.1016/s0021-9673(01)93718-5. [PMID: 6736150]
  • K B Agrawal, B Prasad, V K Sobti. Physiological and biochemical effects of glyceryl guaiacolate-thiopentone sodium anaesthesia in buffalo calves. Research in veterinary science. 1983 Jul; 35(1):53-7. doi: 10.1016/s0034-5288(18)32202-1. [PMID: 6622844]
  • C E Matheson, J E Murphy, S H Gibson, S Moffitt. The effect of acute guaifenesin administration on serum uric acid. Drug intelligence & clinical pharmacy. 1982 Apr; 16(4):332-4. doi: 10.1177/106002808201600414. [PMID: 7067625]
  • H C Ketelaars, J G Peters. Determination of guaiphenesin and its metabolite, beta-(2-methoxyphenoxy)-lactic acid, in plasma by high-performance liquid chromatography. Journal of chromatography. 1981 Jun; 224(1):144-8. doi: 10.1016/s0378-4347(00)80149-8. [PMID: 7263812]
  • L I Harrison, S F Chang, T M Welscher, R E Ober. Comparative absorption of theophylline from theophylline-guaifenesin tablets and liquid and from a reference theophylline liquid. Clinical therapeutics. 1981; 4(1):18-23. doi: NULL. [PMID: 7273065]
  • J A Hubbell, W W Muir, R A Sams. Guaifenesin: cardiopulmonary effects and plasma concentrations in horses. American journal of veterinary research. 1980 Nov; 41(11):1751-5. doi: NULL. [PMID: 7212404]
  • S Singhawangcha, C F Poole, A Zlatkis. The determination of bifunctional compounds. IX. A selective reaction for the determination of guaifenesin in plasma by gas chromatography. Journal of chromatography. 1980 Oct; 183(4):433-9. doi: 10.1016/s0378-4347(00)81585-6. [PMID: 7430296]
  • G Kauert, L von Meyer, G Drasch. [Investigations of guaifenesine metabolism with gas chromatography-mass spectrometry]. Archives of toxicology. 1980 Jul; 45(2):149-59. doi: 10.1007/bf01270913. [PMID: 7469792]
  • J W Barnhart, E N Massad. Determination of dextromethorphan in serum by gas chromatography. Journal of chromatography. 1979 Aug; 163(4):390-5. doi: 10.1016/s0378-4347(00)81642-4. [PMID: 544605]
  • H Schad, H Brechtelsbauer. Thoracic duct lymph in conscious dogs at rest and during changes of physical activity. Pflugers Archiv : European journal of physiology. 1977 Jan; 367(3):235-40. doi: 10.1007/bf00581360. [PMID: 556846]
  • J R Brown, T H Self, W J Taylor, W W Stargel, R L Boswell. Guaifenesin effects on the guaiac test for occult blood. JAMA. 1976 Oct; 236(16):1881. doi: NULL. [PMID: 989543]
  • W Wilde. [Early diagnosis and early treatment of chronic bronchial diseases for the prevention of early invalidity]. Zeitschrift fur Allgemeinmedizin. 1975 Nov; 51(31):1438-9. doi: ". [PMID: 1199180]
  • H Weuta. [Clinical investigation of a combination preparation of ampicillin, theophylline, papaverine-HCl and guaiacolglyceryl ether. 1. In form of tablets]. Arzneimittel-Forschung. 1974 Dec; 24(12):2035-44. doi: NULL. [PMID: 4615715]
  • H Weuta. [Clinical investigation of a combination preparation of ampicillin, theophylline, papaverine-HCl and guaiacolglyceryl ether. 2. In form of syrup]. Arzneimittel-Forschung. 1974 Dec; 24(12):2044-8. doi: NULL. [PMID: 4615716]
  • C M Ramsdell, A E Postlethwaite, W N Kelley. Uricosuric effect of glyceryl guaiacolate. The Journal of rheumatology. 1974 Mar; 1(1):114-6. doi: NULL. [PMID: 4617771]
  • W Günthner. [Therapy of the chronic bronchitis syndrome]. Fortschritte der Medizin. 1973 Feb; 91(4):169-71. doi: NULL. [PMID: 4701766]
  • W J Vandenheuvel, J L Smith, R H Silber. -(2-Methoxyphenoxy)lactic acid, the major urinary metabolite of glyceryl guaiacolate in man. Journal of pharmaceutical sciences. 1972 Dec; 61(12):1997-8. doi: 10.1002/jps.2600611226. [PMID: 4638115]
  • S I Naito, M Mizutani, S Osumi, T Mikawa, K Sekishiro, K Nakao, H Wakita. Biopharmaceutical studies on guaiacol glyceryl ether and related compounds. V. Journal of pharmaceutical sciences. 1972 Aug; 61(8):1212-5. doi: 10.1002/jps.2600610808. [PMID: 4403205]
  • R F McGregor, G Phillips, M M Romsdahl. Analysis of urinary 5-hydroxyindoleacetic acid by thin layer chromatography: elimination of interference by glyceryl guaiacolate. Clinica chimica acta; international journal of clinical chemistry. 1972 Aug; 40(1):59-65. doi: 10.1016/0009-8981(72)90251-3. [PMID: 5056642]
  • H E Garner, J P Rosborough, J F Amend. Effects of glyceryl guaiacolate on certain serum, plasma and cellular parameters in ponies. Veterinary medicine, small animal clinician : VM, SAC. 1972 Apr; 67(4):408-12. doi: NULL. [PMID: 4481986]
  • M Gillbrand. [Sources of error of practical significance in the determination of urinary 5-HIAA]. Lakartidningen. 1971 May; 68(21):2454-5. doi: NULL. [PMID: 5556151]
  • F Rossberg, D Luther. [Animal experiment on the absorption, distribution and elimination of C 14 - and H 3 -labelled guaiacol-glyceryl-ether]. Acta biologica et medica Germanica. 1971; 26(2):331-9. doi: NULL. [PMID: 5142865]
  • R Gorski, D Luther, F Rossberg, R Sinz, N Tiedt. [Resorption, distribution and excretion of guaiacol glyceryl ether and its effect on the physiological parameters]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete. 1970 Jul; 25(13):589-97. doi: NULL. [PMID: 5523268]
  • L E Davis, W A Wolff. Pharmacokinetics and metabolism of glyceryl guaiacolate in ponies. American journal of veterinary research. 1970 Mar; 31(3):469-73. doi: NULL. [PMID: 5440793]
  • A T Pedersen, J G Batsakis, N A Vanselow, J A McLean. False-positive tests for urinary 5-hydroxyindoleacetic acid. Error in laboratory determinations caused by glyceryl guaiacolate. JAMA. 1970 Feb; 211(7):1184-6. doi: NULL. [PMID: 5466975]
  • W Wilde. [Long term and permanent treatment of spastic bronchial diseases]. Hippokrates. 1969 Nov; 40(22):886-9. doi: ". [PMID: 5387014]
  • S I Naito, M Mizutani, K Kitao, S Nishimura. Biopharmaceutical studies on guiacol glycerol ether and related compounds. 3. Metabolites of guaiacol glycerol ether and its mononicotinate. 1. Chemical & pharmaceutical bulletin. 1969 Sep; 17(9):1794-8. doi: 10.1248/cpb.17.1794. [PMID: 5347590]
  • M Mizutani, S Naito. Studies on absorption and excretion of drugs. XXIX. Biopharmaceutical studies on guaiacol glycerol ether and related compounds. I. Blood level of guaiacol glycerol ether in rabbit and its binding with serum proteins. Chemical & pharmaceutical bulletin. 1967 Sep; 15(9):1422-6. doi: 10.1248/cpb.15.1422. [PMID: 5583721]
  • R D Eastham, E P Griffiths. Reduction of platelet adhesiveness and prolongation of coagulation-time of activated plasma by glyceryl guaiacolate. Lancet (London, England). 1966 Apr; 1(7441):795-6. doi: 10.1016/s0140-6736(66)91867-8. [PMID: 4159996]
  • J BASTECKY, J LAURENTOVA, H ZAPLAT'ILKOVA. [RAPID METHOD FOR DETERMINING GUAIACURAN IN THE URINE]. Activitas nervosa superior. 1963 May; 5(?):223-4. doi: NULL. [PMID: 14070667]
  • J LAURENTOVA, J BASTECKY, J ECKERTOVA, H ZAPLATILKOVA. [USE OF REACTIONS TO PSYCHOPHARMACOLOGICAL AGENTS IN THE URINE IN PSYCHIATRIC PRACTICE]. Activitas nervosa superior. 1963 May; 5(?):195-7. doi: NULL. [PMID: 14073986]
  • A M MORGAN, E H TRUITT, J M LITTLE. Plasma levels of mephenesin, mephenesin carbamate, guaiacol glyceryl ether, and methocarbamol (AHR-85) after oral and intravenous administration in the dog. Journal of the American Pharmaceutical Association. American Pharmaceutical Association. 1957 Jun; 46(6):374-7. doi: 10.1002/jps.3030460613. [PMID: 13491400]